Dr. Kortagere is interested in designing and developing small-molecule modulators to treat neurodegenerative diseases. Her laboratory is specifically interested in biased signaling and functional selectivity of dopamine receptor agonists and allosteric modulators of catecholamine transporters.
Biased signaling of dopamine D3 receptor agonists; developing symptomatic and disease-modifying therapeutics for Parkinson’s disease; etiology of mild cognitive impairment in Parkinson’s disease; role of dopamine receptors in neurocognitive impairment in HIV and other neuronal infections.